Skopos Labs, Inc. Codexis, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 8,610 shares of CDXS stock, worth $19,372. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,610
Previous 4,986
72.68%
Holding current value
$19,372
Previous $23,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
63.7MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$21.4 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$18.2 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$10.6 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$6.75 Million1.17% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $147M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...